Sector revisions GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 14:24:17 25/06/2026 +04			5-day change	1st Jan Change
2,358.85 ^INR	+0.18%		+1.11%	-4.54%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED							4
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							29
	ROCHE HOLDING AG							18
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	NOVO NORDISK A/S							24
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	VERTEX PHARMACEUTICALS INCORPORATED							29
	BRISTOL-MYERS SQUIBB COMPANY							25
	GSK PLC							19
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	BAYER AG							18
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							16
	Average							22
	Weighted average by Cap.							25